On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.
On April 15, the U.S. Food and Drug Administration (FDA) approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Read more.